Magacho Leopoldo, Shetty Rajesh K
1 Ophthalmology Department, Hospital VER-Excellence in Ophthalmology, Federal University of Goiás, CEROF-UFG, Goiânia - Brazil.
Eur J Ophthalmol. 2014 Mar-Apr;24(2):196-201. doi: 10.5301/ejo.5000349. Epub 2013 Aug 7.
To report the results of combined ab externo and ab interno revision with mitomycin C (MMC) of failed filtering blebs in glaucoma patients.
Glaucoma patients with a failed trabeculectomy who had undergone internal and external revision with MMC in the last 6 years with at least 12 months of follow-up were considered. All study patients followed the same protocol in the operating room: injection of 0.2 mL of MMC (0.4 mg/mL) 2 cm lateral from the bleb followed by internal revision with an iris spatula and external revision with a 26-G × ½" needle. Success was defined as an intraocular pressure (IOP) ≥6 mm Hg and ≤18 mm Hg with (qualified) or without (absolute) any ocular hypotensive drugs.
The study included 25 eyes of 22 glaucoma patients. Mean age was 65.2 ± 10.5 years. Mean follow-up was 26.9 ± 10.3 months. The IOP was reduced from 24.5 ± 6.0 mm Hg preoperatively to 10.0 ± 3.3 mm Hg at the last visit (p<0.001). The number of ocular hypotensive medications was reduced from 1.8 ± 1.0 to 0.2 ± 0.6 (p<0.001). There was no change in visual acuity (0.83 ± 0.75 vs 0.83 ± 0.74, p = 0.7). Three patients developed choroidal detachment, another eye had a transient hypotony with maculopathy, and 2 patients developed cataract. Absolute success was achieved in 80% of eyes, and qualified success in 16% of eyes.
Combined ab externo and ab interno revision with MMC can be an effective technique to revitalize failed filtering blebs in glaucoma patients with minimal complications.
报告青光眼患者失败滤过泡联合外路和内路修复并使用丝裂霉素C(MMC)的结果。
纳入过去6年接受内路和外路MMC修复且至少随访12个月的小梁切除术失败的青光眼患者。所有研究患者在手术室遵循相同方案:在滤过泡外侧2 cm处注射0.2 mL MMC(0.4 mg/mL),随后用虹膜铲进行内路修复,并用26G×½英寸针头进行外路修复。成功定义为眼压(IOP)≥6 mmHg且≤18 mmHg,使用(合格)或不使用(绝对)任何降眼压药物。
该研究纳入22例青光眼患者的25只眼。平均年龄为65.2±10.5岁。平均随访时间为26.9±10.3个月。眼压从术前的24.5±6.0 mmHg降至末次随访时的10.0±3.3 mmHg(p<0.001)。降眼压药物数量从1.8±1.0减少至0.2±0.6(p<0.001)。视力无变化(0.83±0.75 vs 0.83±0.74,p = 0.7)。3例患者发生脉络膜脱离,另一只眼出现短暂低眼压伴黄斑病变,2例患者发生白内障。80%的眼实现绝对成功,16%的眼实现合格成功。
联合外路和内路MMC修复是使青光眼患者失败滤过泡恢复活力且并发症最少的有效技术。